A scoping review and evidence map of radiofrequency field exposure and genotoxicity: assessing in vivo, in vitro, and epidemiological data
This scoping review and evidence map (PRISMA-ScR) summarizes over 500 studies on RF-EMF exposure and genotoxicity across in vitro, in vivo, and epidemiological research. The authors report a higher proportion of significant DNA damage findings in in vivo and epidemiological studies than in vitro studies, with DNA base damage commonly reported under real-world/pulsed/GSM talk-mode conditions and longer exposures. They conclude that DNA damage has been observed at exposure levels below ICNIRP limits and recommend precautionary measures and updates to guidelines to address potential non-thermal effects.
Key points
- The review mapped 500+ RF-EMF genotoxicity studies across in vitro (53%), in vivo (37%), and epidemiological (10%) designs.
- In vivo and epidemiological studies reportedly showed a higher proportion of significant DNA damage effects than in vitro studies.
- DNA base damage was described as the most common marker, especially with GSM talk-mode, pulsed signals, real devices, and longer exposure durations.
- The authors report a U-shaped dose-response pattern and discuss oxidative stress/free radicals as potential non-thermal mechanisms.
- Funding source was reported to predict experimental outcomes more strongly than study quality assessments.
- The authors state that 58% of studies observing DNA damage used exposures below ICNIRP limits, including some at much lower intensities.
- The paper argues current guidelines focused on thermal effects may not address chronic low-level exposure and recommends precautionary approaches (e.g., ALARA, labeling, independent oversight).
Referenced studies & papers
Relevant papers in OpenMel
Source:
Open original
AI-generated summaries may be incomplete or incorrect. This content is for informational purposes only and is not medical advice.
AI-generated summaries may be incomplete or incorrect. This content is for informational purposes only and is not medical advice.
Comments
Log in to comment.
No comments yet.